Indian pharma firms exporting to the US often overlook tax strategies that could protect margins and boost profitability. With pressure from regulatory costs and tariff structures, every percentage point saved counts. Learn the top tax planning levers to reduce risk, improve cash flow, and safeguard your bottom line in the US market. https://indamadvisors.com/how-lack-of-us-tax-planning-reduces-profit-margins-for-indian-pharmaceutical/